PhD, Molecular Pharmacology
University of Wolverhampton, Wolverhampton, United Kingdom
MSc, Biomedical Sciences
Nottingham Trent University, Nottingham, United Kingdom
BPharm
Mangalore University, Konaje, India
Vijay D’Souza, PhD, is a Senior Research Associate in the Market Access and Outcomes Strategy group at RTI-HS and is based in Cambridge, UK. In his current role, Vijay works on developing HEOR strategic plans, HTA submissions, Global value dossiers and systematic literature reviews. He has over 5 years of cross-functional experience in evidence synthesis and market access projects including primary research in pricing, reimbursement, and strategic market access. Vijay has experience in a broad range of therapy areas including lung diseases, oncology, ophthalmology, cardiovascular disorders, autoimmune diseases, rare genetic disorders and medical devices. Vijay’s strategic market access experience includes testing target product profile, pricing assumptions, regulatory environments, horizon scanning and early access consideration in US, EU5 and emerging markets. Vijay also has a background in respiratory research and translational clinical trials and has published in several peer reviewed journals covering diverse therapeutic areas.